5.82
+0.065(+1.13%)
Currency In USD
Previous Close | 5.76 |
Open | 5.79 |
Day High | 5.98 |
Day Low | 5.61 |
52-Week High | 41.22 |
52-Week Low | 4.83 |
Volume | 28,524 |
Average Volume | 233,880 |
Market Cap | 14.67M |
PE | -0.45 |
EPS | -12.93 |
Moving Average 50 Days | 7.25 |
Moving Average 200 Days | 11.15 |
Change | 0.07 |
If you invested $1000 in Imunon, Inc. (IMNN) 10 years ago, it would be worth $0.88 as of September 09, 2025 at a share price of $5.82. Whereas If you bought $1000 worth of Imunon, Inc. (IMNN) shares 5 years ago, it would be worth $32.33 as of September 09, 2025 at a share price of $5.82.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
IMUNON to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 02, 2025 12:05 PM GMT
LAWRENCEVILLE, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, today announced that a pre-recorded presentation from the Company will be avai
IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
GlobeNewswire Inc.
Aug 28, 2025 12:05 PM GMT
LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company has regained compliance with the minimum bid pri
IMUNON Recaps Highlights from 2025 Second Quarter Financial Results Conference Call
GlobeNewswire Inc.
Aug 05, 2025 8:00 PM GMT
Investors are reminded that Shareholders of record as of August 7, 2025, will receive a 15% stock dividend payment LAWRENCEVILLE, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development w